Pfizer Inc (NYSE:PFE)

39.40
Delayed Data
As of 4:02pm ET
 +0.59 / +1.52%
Today’s Change
29.96
Today|||52-Week Range
43.08
+7.04%
Year-to-Date
Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know
5:45pm / Zacks.com - Paid Partner Content
AstraZeneca (AZN) COVID-19 Jab's New Side Effect Stated by EMA
Jun 14 / Zacks.com - Paid Partner Content
There Could Be Fireworks at Wednesday's Glaxo Investor Day
4:26pm / GuruFocus News - Paid Partner Content
Will This News Stop Ocugen Shares in Their Tracks?
Jun 14 / MotleyFool.com - Paid Partner Content
If You Thought These 2 Big Nasdaq Winners Were Done, Think Again
3:02pm / MotleyFool.com - Paid Partner Content
How Big Is Bristol Myers Squibb's Latest FDA Approval?
Jun 13 / MotleyFool.com - Paid Partner Content
Why BioNTech Stock Is Rising Today
11:58am / MotleyFool.com - Paid Partner Content
Is Pfizer Stock Undervalued?
Jun 13 / MotleyFool.com - Paid Partner Content
AstraZeneca (AZN) Gets Court Order to Supply COVID-19 Jabs in EU
9:50am / Zacks.com - Paid Partner Content
3 Reasons to Buy Moderna, and 1 Reason to Sell
Jun 13 / MotleyFool.com - Paid Partner Content
Will Emergence of COVID-19 Delta Variant Aid Vaccine Makers?
9:29am / Zacks.com - Paid Partner Content
4 High-Yield Dividend Stocks to Watch
Jun 12 / MotleyFool.com - Paid Partner Content
Why Is Everyone Talking About CureVac Stock?
6:13am / MotleyFool.com - Paid Partner Content
Company News for Jun 11, 2021
Jun 11 / Zacks.com - Paid Partner Content
If You Invested $10,000 in Ocugen in December, This Is How Much You Would Have Today
Jun 20 / MotleyFool.com - Paid Partner Content
COVID-19 Jabs of Pfizer & Moderna May Lead to Inflamed Heart
Jun 11 / Zacks.com - Paid Partner Content
How This Pharma Company Can Benefit From Its Competitors
Jun 20 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: FDA Approval for NVO, PFE Products & Other Updates
Jun 11 / Zacks.com - Paid Partner Content
Pfizer's COVID Vaccine Is Even More Amazing Than You Think
Jun 19 / MotleyFool.com - Paid Partner Content
Which Company Will Dominate the Teen Vaccination Market This Fall?
Jun 11 / MotleyFool.com - Paid Partner Content
What to Make of the CDC's Latest Efficacy Data on Pfizer's and Moderna's COVID Vaccines
Jun 19 / MotleyFool.com - Paid Partner Content
Pfizer Can Now Vaccinate Teens. Will This Boost Orders?
Jun 11 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: AZN COVID-19 Antibody Cocktail Failure, GSK New Cancer Deal
Jun 18 / Zacks.com - Paid Partner Content
3 Absurdly Cheap Stocks to Buy in a Ridiculously Expensive Market
Jun 11 / MotleyFool.com - Paid Partner Content
12 Words From CureVac's CEO That Could Mean Billions for Moderna and Pfizer
Jun 18 / MotleyFool.com - Paid Partner Content
CDC Finds Higher-Than-Expected Heart Inflammation Cases in Young Men Following COVID Vaccine Jabs
Jun 10 / MotleyFool.com - Paid Partner Content
How Does Novavax Stack Up Against Today's Vaccine Leaders?
Jun 18 / MotleyFool.com - Paid Partner Content
Moderna Files for FDA Approval of Its COVID Vaccine in Teens
Jun 10 / MotleyFool.com - Paid Partner Content
Why BioNTech, Moderna, and Novavax Stocks Sank This Week
Jun 18 / MotleyFool.com - Paid Partner Content
Why Shares of Novavax Crashed 37.7% in May
Jun 10 / MotleyFool.com - Paid Partner Content
Why CureVac Stock Is Getting Crushed Today
Jun 17 / MotleyFool.com - Paid Partner Content
Why Shares of Vaxart Plummeted 38.6% in May
Jun 10 / MotleyFool.com - Paid Partner Content
CureVac (CVAC) Plummets on Disappointing COVID-19 Vaccine Data
Jun 17 / Zacks.com - Paid Partner Content
Merck (MRK) Signs $1.2B Deal With US for COVID-19 Therapeutic
Jun 10 / Zacks.com - Paid Partner Content
CureVac shares drop 45% after disappointing Covid vaccine results
Jun 17 / CNN.com - Paid Partner Content
How Does Moderna Measure up to Bigger Rival Pfizer?
Jun 10 / MotleyFool.com - Paid Partner Content
Why BioNTech Stock Was Sliding Today
Jun 16 / MotleyFool.com - Paid Partner Content
3 Dividend Stocks Wall Street Thinks Will Soar 20% or More
Jun 10 / MotleyFool.com - Paid Partner Content
Why Pfizer's About to Sell 500 Million COVID Vaccine Doses Without Making a Dime
Jun 16 / MotleyFool.com - Paid Partner Content
Why BioNTech Blew Past the Market on Wednesday
Jun 09 / MotleyFool.com - Paid Partner Content
3 Great Reasons to Buy Novavax
Jun 15 / MotleyFool.com - Paid Partner Content
2 High-Yield Dividend Stocks for 2021
Jun 09 / MotleyFool.com - Paid Partner Content
How Worrisome Are Heart Issues Reported With Pfizer's and Moderna's COVID Vaccines?
Jun 15 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Gets FDA Nod for Pneumococcal Vaccine Prevnar 20
Jun 09 / Zacks.com - Paid Partner Content
Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know
Jun 14 / Zacks.com - Paid Partner Content
Up 100% in a Year, Can This Animal Health Stock Keep Climbing?
Jun 09 / MotleyFool.com - Paid Partner Content
Ascendis' (ASND) BLA for GHD Candidate Gets Review Extension
Jun 14 / Zacks.com - Paid Partner Content
Could Ocugen Be a Millionaire-Maker Stock?
Jun 09 / MotleyFool.com - Paid Partner Content
J&J (JNJ) Gets FDA Nod for 10M COVID Vaccines, Discards Many
Jun 14 / Zacks.com - Paid Partner Content
What Investors Need to Know From Pfizer's Earnings Report
Jun 09 / MotleyFool.com - Paid Partner Content